Related Experiment Video
Updated: Sep 21, 2025

Experimental and Imaging Techniques for Examining Fibrin Clot Structures in Normal and Diseased States
Published on: April 1, 2015
Hypercoagulability Impairs Plaque Stability in Diabetes-Induced Atherosclerosis
Saira Ambreen1, Sameen Fatima1,2, Ahmed Elwakiel1
1Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostic, University Hospital Leipzig, 04103 Leipzig, Germany.
Impaired thrombomodulin (TM) function in diabetes reduces atherosclerotic plaque stability. This dysfunction contributes to unstable plaques, increasing mortality risk in diabetic patients.
Area of Science:
- Cardiovascular Biology
- Metabolic Disease Research
- Thrombosis and Hemostasis
Background:
- Diabetes mellitus accelerates atherosclerosis, a leading cause of mortality in diabetic individuals.
- Diabetes-associated atherosclerosis involves reduced endothelial thrombomodulin (TM) expression and impaired activated protein C (aPC) generation.
- Current therapeutic strategies for diabetes-associated atherosclerosis remain insufficient.
Purpose of the Study:
- To investigate the role of impaired thrombomodulin (TM) function in the stability of atherosclerotic plaques in a diabetic mouse model.
- To elucidate the impact of dysfunctional TM on plaque composition and characteristics under hyperglycemic conditions.
Main Methods:
- Utilized hyperglycemic mice expressing dysfunctional TM (TMPro/Pro) crossed with ApoE-/- mice to model diabetes-associated atherosclerosis.
- Analyzed atherosclerotic lesion size, lipid accumulation, necrotic core area, fibrous cap thickness, and immune cell infiltration (macrophages, smooth muscle cells) in the truncus brachiocephalic.
Main Results:
- Diabetic TMPro/Pro ApoE-/- mice exhibited reduced plaque stability compared to diabetic ApoE-/- mice.
- While overall plaque and lumen size were smaller, TMPro/Pro mice showed larger necrotic cores and thinner fibrous caps, indicative of instability.
- Lesions in diabetic TMPro/Pro mice contained more macrophages and fewer smooth muscle cells.
Conclusions:
- Impaired thrombomodulin (TM) function exacerbates atherosclerotic plaque instability in the context of hyperglycemia.
- Dysfunctional TM contributes to a pro-coagulant phenotype and promotes the development of unstable atherosclerotic lesions.
- Targeting TM function may offer a therapeutic avenue for managing diabetes-associated atherosclerosis.
More Related Videos
07:36Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
09:41Quantification of Monocyte Transmigration and Foam Cell Formation from Individuals with Chronic Inflammatory Conditions
Published on: October 17, 2017
Related Concept Videos
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...